{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-23-018163","form_type":"8-K","ticker":null,"cik":"0001617765","company_name":"EVOME MEDICAL TECHNOLOGIES INC.","filed_at":"2023-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.572575+00:00","generated_at":"2026-06-10T14:50:44.508176+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Salona Global subsidiary Biodex Medical Systems enters $3M secured revolving credit agreement with Pathward","bullets":["Biodex Medical Systems, subsidiary of Salona Global, entered a secured revolving loan facility of up to $3.0 million from Pathward on September 12, 2023.","Approximately $1.7 million was immediately available; variable interest rate equals greater of 6% per annum or prime + 0.75%.","Loan is payable on demand and secured by personal property of Borrower, Salona Global, and several guarantors including Inspira Financial, Mio-Tech, Simbex, and DaMar.","Debt complements existing credit facilities with Pathward through other subsidiaries; Guaranty executed by all guarantors."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-23-018163","json":"https://secwatch.observer/filing/0001062993-23-018163.json","markdown":"https://secwatch.observer/filing/0001062993-23-018163.md","text":"https://secwatch.observer/filing/0001062993-23-018163.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/0001062993-23-018163-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T14:50:44.508176+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a74960a0bd40f9c45072fa1b4e58fecfc5fb2033","claim":"EVOME MEDICAL TECHNOLOGIES INC. incurred guarantee with Pathward, National Association.","evidence_excerpt":"(“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the \"Agreement\"), of which approximately US $1.7 million was available to be borrowed as of September 12, 2023.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/0001062993-23-018163-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"guarantee"},{"label":"Counterparty","value":"Pathward, National Association"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"db2af1e8e1ef567a74f05e311cfff3ff0fd34864","claim":"EVOME MEDICAL TECHNOLOGIES INC. incurred revolving credit of up to $3.0 million with Pathward, National Association at the greater of 6.00% per annum or 0.75% in excess of the rate shown in the Wall.","evidence_excerpt":"On September 12, 2023, an operating subsidiary of Salona Global Medical Device Corporation (“Company”), Biodex Medical Systems, Inc. (“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the \"Agreement\"), of which approximately US $1.7 million was available to be borrowed as of September 12, 2023.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/0001062993-23-018163-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"up to $3.0 million"},{"label":"Counterparty","value":"Pathward, National Association"},{"label":"Rate","value":"the greater of 6.00% per annum or 0.75% in excess of the rate shown in the Wall"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"736625ba8f69477177c6ab5e701ba9267d546255","claim":"EVOME MEDICAL TECHNOLOGIES INC. entered into Master Credit and Security Agreement with Pathward, National Association valued at up to $3.0 million (effective 2023-09-12).","evidence_excerpt":"On September 12, 2023, an operating subsidiary of Salona Global Medical Device Corporation (“Company”), Biodex Medical Systems, Inc. (“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the \"Agreement\")","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1617765/000106299323018163/0001062993-23-018163-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Pathward, National Association"},{"label":"Value","value":"up to $3.0 million"},{"label":"Effective","value":"2023-09-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}